trans-[IrCl(C2R2)(PPr3i)2] complexes are prepared from [(C8H14)2IrCl]2, PPr3i and C2R2 (R = H, Me, Ph) via the intermediate [IrCl(PPr3i)2]. With phenylacetylene, a mixture of two isomers, trans-[IrCl(PhC2H)(PPr3i)2] and IrHCl(C2Ph)(PPr3i)2 is formed which reacts with pyridine to give IrHCl(C2Ph)(py)(PP3i)2. Reaction of trans-[IrCl(C2Ph2)(PPr3i)2] with NaC5H5 yields the compound C5H5Ir(C2Ph2)PPr3i (VI)
由[(C 8 H 14)2 IrCl] 2,PPr 3 i和C 2 R 2(R = H,Me,Ph)制备反式-[IrCl(C 2 R 2)(PPr 3 i)2 ]配合物通过中间体[IrCl(PPr 3 i)2 ]。与苯基
乙炔,两种异构体的混合物,反式-[IrCl(PhC 2 H)(PPr 3 i)2 ]和IrHCl(C 2 Ph)(PPr 3 i)2形成与
吡啶反应的化合物,得到IrHCl(C 2 Ph)(py)(PP 3 i)2。的反应的反式- [的IrCl(C 2博士2)(PPR 3我)2 ]与
NAC 5 ħ 5个收率的化合物C 5 H ^ 5的Ir(C 2博士2)PPR 3我(VI),其经由所述
乙烯基转化络合物C 5 H 5 Ir(CPhCHPh)(OCOCF 3)PPr 3 i(VII)转化为
铱-
茚满衍
生物derivative。C 5 H 5 Ir(OCOCF 3)2 PPr 3 i,C